In Europe alone, approximately 2 million people live with chronic inflammatory bowel diseases (IBD), and their incidence has ...
A global research collaboration has revealed how certain gut cells switch on pain signals, which can linger long after the ...
Many insured US patients living with IBD face challenges to health care access, which has resulted in them skipping or rationing medication.
A study revealed that IBD patients, particularly those with ulcerative colitis and multiple biologic treatments, face an ...
Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...
In a recent study published in the Journal of Crohn’s and Colitis, researchers showed that oral vancomycin (OV) induces ...
A new study suggests that men with inflammatory bowel disease (IBD) may face a significantly higher risk of developing heart disease over time.
Severe abdominal pains, unpredictable bowel movements and fatigue are some of the serious symptoms 180,000 Australians live ...
An antibiotic used to treat infective diarrhoea may be an effective drug for a type of inflammatory bowel disease, according ...
Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...
The most common reason for delaying or not receiving care was not getting an appointment when they needed one, cited by 39% of respondents. More than half (56%) of patients reported delays in ...
Vancomycin could offer new therapeutic option for patients with a type of inflammatory bowel disease
An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback